FDA Leadership & Health Policy
Latest in FDA Leadership & Health Policy· Nov 5
A US-funded vaccine trial in Guinea-Bissau was halted over ethics violations, raising questions about oversight of American-backed research in developing nations. The cancellation will delay pharmaceutical development timelines for the vaccine in question and dampen investor confidence in research infrastructure across West Africa. Ethics breaches in trials targeting vulnerable populations trigger regulatory reviews of similar studies and heightened scrutiny of US funding mechanisms for international research.
Senate confirmation hearings and policy positions of FDA nominees regarding vaccines, pharmaceuticals, food safety, and public health regulation.
3 events tracked
- Single source8 days ago
US-backed vaccine study halted in Guinea-Bissau over ethics concerns
A US-funded trial testing a vaccine on infants in Guinea-Bissau was scrapped after critics called it unethical for withholding the vaccine from half the participants.
BBC News
- Single source15 days ago
RFK Jr. plans to permit widespread access to unapproved peptide shots
RFK Jr. signals he will permit unapproved peptide injections, loosening FDA enforcement on experimental treatments.
The New York Times
- Single sourceabout 2 months ago
Overton confronted on vaccine claims and tobacco policy at FDA confirmation hearing
The FDA nominee faced Senate questioning about presidential statements on measles vaccines and tobacco regulation during her confirmation hearing.
The New York Times